HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

PORT-INTRA-ABDOMINAL CATHETER SYSTEMS IN THE COMBINED TREATMENT OF GASTRIC CANCER

Download full text PDF
Issue: 
12
Year: 
2017

Professor A. Chernousov, MD, Academician of the Russian Academy of Sciences; Professor T. Khorobrykh, MD; D. Vychuzhanin, Candidate of Medical Sciences; N. Kharlov; R. Nurutdinov, Candidate of Medical Sciences; N. Abdulkhakimov University Clinical Hospital One, N.N. Burdenko Clinic of Intermediate-Level Surgery, I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper discusses the most topical issues related to port-intra-abdominal catheter systems that provide simple and safe access for drug administration into the abdominal cavity.

Keywords: 
oncology
intraperitoneal chemotherapy
gastric cancer
peritoneal carcinomatosis
port-intra-abdominal catheter system (B. Braun Medical Inc.)



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Kaprin A.V., Starinskij V.V., Petrova G.V. Zlokachestvennye zabolevanija v Rossii v 2013godu (zabolevaemost' i smertnost') / M.: MNIOI im. P.A.Gertsena – filial FGBU «FMITs im. P.A. Gertsena» Minzdrava Rossii, 2015; p. 4–13.
  2. Ishigami, S., Uenosono, Y., Arigami, T. et al. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer // World J. Surg. Oncol. – 2014; 12: 350.
  3. Peng Y., Imano M., Itoh T. et al. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer // J. Surg. Oncol. – 2015; 111 (8): 1041–6.
  4. Nered S.N., Klimenkov A.A., Stilidi I.S. i dr. Hirurgicheskoe i kombinirovannoe lechenie bol'nyh rakom zheludka s vysokim riskom implantatsionnogo metastazirovanija. Zasedanie Moskovskogo Onkologicheskogo Obschestva №529; tema Intraoperatsionnaja himioterapija: otsenka effektivnosti vozdeĭstvija na intraperitoneal'nye mestastazy. 2008, RONTs im. N.N.Blohina.
  5. Sugarbaker P., Bijelic L. Adjuvant bidirectional chemotherapy using an intraperitoneal port // Gastroenterol. Res. Pract. – 2012; 2012: 752643.
  6. Radulescu C., Tufeanu D., Mintioan C. et al. Intraperitoneal chemotherapy for advanced gastric cancer // TMJ. – 2008; 59: 49–55.
  7. Abdurahmanov B.A., Gantsev Sh.H., Kulakeev O.K., Vozmozhnosti peritoneal'nyh port-sistem v lechenii diuretikorezistentnogo astsita u bol'nyh tsirrozom pecheni // Hirurgija. Zhurnal im. N.I. Pirogova. – 2010; 4: 30–3.
  8. Keen A., Fitzgerald D., Bryant A. et al. Management of drainage for malignant ascites in gynaecological cancer // Cochrane Database Syst. Rev. – 2010; 1: CD007794.
  9. Markman M., Walker J. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment // J. Clin. Oncol. – 2006; 24 (6): 988–94.
  10. Henretta M., Anderson C., Angle J. et al. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters // Gynecol. Oncol. – 2011; 123 (2): 342–5.
  11. Makhija S., Leitao M., Sabbatini P. et al. Complications associated with intraperitoneal chemotherapy catheters // Gynecol. Oncol. – 2001; 81 (1): 77–81.
  12. Walker J., Armstrong D., Huang H. et al. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study // Gynecol. Oncol. – 2006; 100 (1): 27–32.
  13. Topuz E., Salihoglu Y., Aydiner A. et al. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer // J. Surg. Oncol. – 2000; 74 (3): 223–6.
  14. Helm C. Ports and complications for intraperitoneal chemotherapy delivery // BJOG. – 2012; 119 (2): 150–9.
  15. Emoto S., Ishigami H., Hidemura A. et al. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis // Jpn. J. Clin. Oncol. – 2012; 42 (11): 1013–9.
  16. Arts H., Willemse P., Tinga D. et al. Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma // Gynecol. Oncol. – 1998; 69 (1): 32–5.
  17. Berry E., Matthews K., Singh D. et al. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer // Gynecol. Oncol. – 2009; 113 (1): 63–7.
  18. Jaka R., Somashekhar S., Zaveri S. et al. Intraperitoneal chemotherapy for epithelial ovarian cancer – single center experience // Indian J. Surg. Oncol. – 2012; 3 (3): 262–6.
  19. Janco J., Hacker M., Konstantinopoulos P. et al. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer // J. Minim. Invasive Gynecol. – 2011; 18 (5): 629–33.
  20. Kinoshita J., Fushida S., Tsukada T. et al. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis // World J. Surg. Oncol. – 2014; 12: 177